• 2025
  Chauvel C, Casalegno JS, Visseaux B, Vieillefond V, Haim-Boukozba S, Enouf V, Chanard E, Fabre M, Rameix-Welti MA, Oblette A, Giannoli JM, Paireau J, Josset L, Lina B, Gaymard A, Cauchemez S, Morfin F, Nunes MC, Bal A, Community and Hospital-Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS-CoV-2 During the 2023-2024 Season, Lyon, France., J Med Virol 2025 Sep; 97(9): e70549.
• 2025
  Claudet A, Alcover N, Lebigot E, Bouhelal HS, Warnakulasuriya F, Soutiere MP, Galloux M, Eleouet JF, Rameix-Welti MA, Bizot E, Vauloup-Fellous C, Portet-Sulla V, Development and evaluation of ELISA serological immunoassays for influenza and respiratory syncytial viruses., Diagn Microbiol Infect Dis 2025 Jul; 112(3): 116835.
• 2025
  Bay P, Martin-Loeches I, Haudebourg AF, Lê MP, Peytavin G, Rameix-Welti MA, Fourati S, de Prost N, How to manage antivirals in critically ill patients with influenza?, Clin Microbiol Infect 2025 Jul; 31(7): 1157-1165.
• 2025
  Lanièce Delaunay C, Nunes B, Monge S, de Lange M, Túri G, Machado A, Latorre-Margalef N, Mlinarić I, Lazar M, Botella Rocamora P, Erdwiens A, Sève N, Domegan L, Martínez-Baz I, Hooiveld M, Oroszi B, Guiomar R, Sperk M, Kurečić Filipović S, Pascu C, Linares Dopido JA, Dürrwald R, Rameix-Welti MA, McKenna A, Castilla J, van Hagen C, Knol M, Bacci S, Kaczmarek M, Kissling E, The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population., Int J Epidemiol 2025 Jun; 54(4): .
• 2025
  Yamagata Y, Toizumi M, Eleouet JF, Rameix-Welti MA, Takeda M, Yoshida LM, Improved RSV Neutralization Assay Using Recombinant RSV Expressing Reporter Fluorescent Protein., Methods Protoc 2025 Jun; 8(3): .
• 2025
  Moisan A, Regue H, Rahou Y, Gaymard A, Oblette A, Avon L, Bergaud N, Chalvignac R, Le Hingrat Q, Burrel S, Jary A, Colson P, Cappy P, Deroche L, Brodard V, Pronier C, Alessandri-Gradt E, Salmona M, Chollet L, Trémeaux P, Handala L, Fourati S, Lina B, Casalegno JS, , Rameix-Welti MA, Josset L, Bal A, Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024., Clin Microbiol Infect 2025 Apr; 31(4): 647-650.
• 2025
  Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA, Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study., Lancet Infect Dis 2025 Mar; 25(3): 301-311.
• 2025
  Blanquart F, Vieillefond V, Visseaux B, Abou Chakra CN, Nunes MC, Jacques A, Haim-Boukobza S, Josset L, Wehrle V, Deleglise G, Duret T, Rameix-Welti MA, Lina B, Enouf V, , Bal A, Influenza vaccine effectiveness against detected infection in the community, France, October 2024 to February 2025., Euro Surveill 2025 Feb; 30(7): .
• 2025
  Traore A, Charniga K, Grellet S, Terpant G, Da Cruz H, Lamy A, Thomas N, Gbaguidi G, Mercier A, Prudhomme J, Visseaux B, Vieillefond V, Haim-Boukobza S, Giannoli JM, , , Castro-Alvarez J, Kouamen AC, Rameix-Welti MA, Beirrera-Ibraim S, Destras G, Josset L, Cauchemez S, Lina B, Coignard B, Schaeffer J, Enouf V, Bal A, Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024., Euro Surveill 2025 Jan; 30(1): .
• 2025
  Alvarez J, Boklund A, Dippel S, Dórea F, Figuerola J, Herskin MS, Michel V, Miranda Chueca MÁ, Nannoni E, Nielsen SS, Nonno R, Riber AB, Stegeman JA, Ståhl K, Thulke HH, Tuyttens F, Winckler C, Brugerolles C, Wolff T, Parys A, Lindh E, Latorre-Margalef N, Rameix Welti MA, Dürrwald R, Trebbien R, Van der Werf S, Gisslén M, Monne I, Fusaro A, Guinat C, Bortolami A, Alexakis L, Enkirch T, Svartstrom O, Willgert K, Baldinelli F, Preite L, Grant M, Broglia A, Melidou A, Preparedness, prevention and control related to zoonotic avian influenza., EFSA J 2025 Jan; 23(1): e9191.
• 2025
  Eléouët JF, Galloux M, Rameix-Welti MA, Visualizing Respiratory Syncytial Virus Replication in Live Mice., Methods Mol Biol 2025 ; 2948(): 281-288.
• 2025
  J RB, V R, Rameix-Welti MA, Visualization of Respiratory Syncytial Virus RNA Synthesis Sites by Ethynyl Uridine Labeling., Methods Mol Biol 2025 ; 2948(): 85-96.
• 2024
  Marougka K, Judith D, Jaouen T, Blouquit-Laye S, Cosentino G, Berlioz-Torrent C, Rameix-Welti MA, Sitterlin D, Antagonism of BST2/Tetherin, a new restriction factor of respiratory syncytial virus, requires the viral NS1 protein., PLoS Pathog 2024 Nov; 20(11): e1012687.
• 2024
  Merdrignac L, Laniece Delaunay C, Verdasca N, Vega-Piris L, O'Donnell J, Sève N, Trobajo-Sanmartín C, Buda S, Hooiveld M, Rodrigues AP, Túri G, Latorre-Margalef N, Mlinarić I, Lazar M, Maurel M, Castrillejo D, Bennett C, Rameix-Welti MA, Martínez-Baz I, Dürrwald R, Meijer A, Melo A, Oroszi B, Hagey TS, Kurečić Filipović S, Dijkstra F, Gomez V, Bacci S, Kaczmarek M, Kissling E, Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024., Influenza Other Respir Viruses 2024 Nov; 18(11): e70009.
• 2024
  Brault A, Pontais I, Enouf V, Debeuret C, Bloch E, Paireau J, Rameix-Welti MA, White M, Baudemont G, Lina B, Parent du Châtelet I, Casalegno JS, Vaux S, Cauchemez S, Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study., Lancet Child Adolesc Health 2024 Oct; 8(10): 721-729.
• 2024
  Laniece Delaunay C, Melo A, Maurel M, Mazagatos C, Goerlitz L, O'Donnell J, Oroszi B, Sève N, Rodrigues AP, Martínez-Baz I, Meijer A, Mlinarić I, Latorre-Margalef N, Lazăr M, Pérez-Gimeno G, Dürrwald R, Bennett C, Túri G, Rameix-Welti MA, Guiomar R, Castilla J, Hooiveld M, Kurečić Filipović S, Samuelsson Hagey T, Dijkstra F, Borges V, Ramos Marín V, Bacci S, Kaczmarek M, Kissling E, Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024., Vaccine 2024 Jul; 42(19): 3931-3937.
• 2024
  Sake SM, Zhang X, Rajak MK, Urbanek-Quaing M, Carpentier A, Gunesch AP, Grethe C, Matthaei A, Rückert J, Galloux M, Larcher T, Le Goffic R, Hontonnou F, Chatterjee AK, Johnson K, Morwood K, Rox K, Elgaher WAM, Huang J, Wetzke M, Hansen G, Fischer N, Eléouët JF, Rameix-Welti MA, Hirsch AKH, Herold E, Empting M, Lauber C, Schulz TF, Krey T, Haid S, Pietschmann T, Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor., Nat Commun 2024 Feb; 15(1): 1173.
• 2024
  Planas D, Staropoli I, Planchais C, Yab E, Jeyarajah B, Rahou Y, Prot M, Guivel-Benhassine F, Lemoine F, Enouf V, Simon-Loriere E, Mouquet H, Rameix-Welti MA, Schwartz O, Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies., Pathog Immun 2024 ; 10(1): 1-11.
• 2024
  Vieira Antão A, Oltmanns F, Schmidt A, Viherlehto V, Irrgang P, Rameix-Welti MA, Bayer W, Lapuente D, Tenbusch M, Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus., Front Immunol 2024 ; 15(): 1376395.
• 2024
  Amarsy R, Granger B, Fournier S, Monteil C, Trystram D, Siorat V, Jarlier V, Robert J, Novel scores relevant to antimicrobial resistance and hospital-acquired infections developed with data from a multi-hospital consortium in the Parisian region of France., J Hosp Infect 2024 Jan; 143(): 97-104.
• 2023
  Diot C, Richard CA, Risso-Ballester J, Martin D, Fix J, Eléouët JF, Sizun C, Rameix-Welti MA, Galloux M, Hardening of Respiratory Syncytial Virus Inclusion Bodies by Cyclopamine Proceeds through Perturbation of the Interactions of the M2-1 Protein with RNA and the P Protein., Int J Mol Sci 2023 Sep; 24(18): .
• 2023
  Diot C, Cosentino G, Rameix-Welti MA, Ribonucleoprotein transport in Negative Strand RNA viruses., Biol Cell 2023 Jan; 115(1): e2200059.
• 2023
  Risso-Ballester J, Rameix-Welti MA, Spatial resolution of virus replication: RSV and cytoplasmic inclusion bodies., Adv Virus Res 2023 ; 116(): 1-43.
• 2022
  Sake SM, Kosch C, Blockus S, Haid S, Gunesch AP, Zhang X, Friesland M, Trummer SB, Grethe C, Kühnel A, Rückert J, Duprex WP, Huang J, Rameix-Welti MA, Empting M, Fischer N, Hirsch AKH, Schulz TF, Pietschmann T, , Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages., Antimicrob Agents Chemother 2022 Dec; 66(12): e0103222.
• 2022
  Schwab LSU, Farrukee R, Eléouët JF, Rameix-Welti MA, Londrigan SL, Brooks AG, Hurt AC, Coch C, Zillinger T, Hartmann G, Reading PC, , Retinoic Acid-Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection., J Infect Dis 2022 Dec; 226(12): 2079-2088.
• 2022
  Cosentino G, Marougka K, Desquesnes A, Welti N, Sitterlin D, Gault E, Rameix-Welti MA, Respiratory syncytial virus ribonucleoproteins hijack microtubule Rab11 dependent transport for intracellular trafficking., PLoS Pathog 2022 Jul; 18(7): e1010619.
• 2022
  Rensen E, Pietropaoli S, Mueller F, Weber C, Souquere S, Sommer S, Isnard P, Rabant M, Gibier JB, Terzi F, Simon-Loriere E, Rameix-Welti MA, Pierron G, Barba-Spaeth G, Zimmer C, Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH., Life Sci Alliance 2022 Apr; 5(4): .
• 2021
  Vauloup-Fellous C, Maylin S, Périllaud-Dubois C, Brichler S, Alloui C, Gordien E, Rameix-Welti MA, Gault E, Moreau F, Fourati S, Challine D, Pawlotsky JM, Houhou-Fidouh N, Damond F, Mackiewicz V, Charpentier C, Méritet JF, Rozenberg F, Podglajen I, Marot S, Petit H, Burrel S, Akhavan S, Leruez-Ville M, Avettand-Fenoel V, Fourgeaud J, Guilleminot T, Gardiennet E, Bonacorsi S, Carol A, Carcelain G, Villemonteix J, Boukli N, Gozlan J, Morand-Joubert L, Legoff J, Delaugerre C, Chaix ML, Roque-Afonso AM, Dortet L, Naas T, Ronat JB, Lepape S, Marcelin AG, Descamps D, , Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients., Eur J Clin Microbiol Infect Dis 2021 Oct; 40(10): 2235-2241.
• 2021
  , , Monocyte distribution width as a biomarker of resistance to corticosteroids in patients with sepsis: the MOCORSEP observational study., Intensive Care Med 2021 Oct; 47(10): 1161-1164.
• 2021
  Brügger M, Démoulins T, Barut GT, Zumkehr B, Oliveira Esteves BI, Mehinagic K, Haas Q, Schögler A, Rameix-Welti MA, Eléouët JF, Moehrlen U, Marti TM, Schmid RA, Summerfield A, Posthaus H, Ruggli N, Hall SRR, Alves MP, , Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection., PLoS Pathog 2021 Jul; 17(7): e1009789.
• 2021
  Risso-Ballester J, Galloux M, Cao J, Le Goffic R, Hontonnou F, Jobart-Malfait A, Desquesnes A, Sake SM, Haid S, Du M, Zhang X, Zhang H, Wang Z, Rincheval V, Zhang Y, Pietschmann T, Eléouët JF, Rameix-Welti MA, Altmeyer R, A condensate-hardening drug blocks RSV replication in vivo., Nature 2021 Jul; 595(7868): 596-599.
• 2021
  Hababou Y, Taleb A, Recoing A, Moreau F, Simon I, Muller de Schongor F, Gault E, Rameix-Welti MA, , Molecular investigation of a RSV outbreak in a geriatric hospital., BMC Geriatr 2021 Feb; 21(1): 120.
• 2021
  Frétaud M, Descamps D, Laubreton D, Rameix-Welti MA, Eléouët JF, Larcher T, Galloux M, Langevin C, , New Look at RSV Infection: Tissue Clearing and 3D Imaging of the Entire Mouse Lung at Cellular Resolution., Viruses 2021 Jan; 13(2): .
• 2021
  Jacque E, Chottin C, Laubreton D, Nogre M, Ferret C, de Marcos S, Baptista L, Drajac C, Mondon P, De Romeuf C, Rameix-Welti MA, Eléouët JF, Chtourou S, Riffault S, Perret G, Descamps D, , Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis., Front Immunol 2021 ; 12(): 683902.
• 2020
  Mascitti H, Bonsang B, Dinh A, Assan F, Perronne V, Leblanc T, Duran C, Bouchand F, Matt M, Le Gal A, N'guyen Van Thanh J, Lanore A, Jacob L, Kiavue N, Siméon S, Bessis S, de Truchis P, Landowski S, Davido B, Moreau F, Rameix-Welti MA, Gault E, Gaillard JL, Roux AL, Sivadon-Tardy V, Salomon E, El Sayed F, Carlier R, Emile JF, Perronne C, Bourgault-Villada I, , Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-sectional Study., Open Forum Infect Dis 2020 Nov; 7(11): ofaa394.
• 2020
  Galloux M, Risso-Ballester J, Richard CA, Fix J, Rameix-Welti MA, Eléouët JF, , Minimal Elements Required for the Formation of Respiratory Syncytial Virus Cytoplasmic Inclusion Bodies In Vivo and In Vitro., mBio 2020 Sep; 11(5): .
• 2020
  Bryche B, Frétaud M, Saint-Albin Deliot A, Galloux M, Sedano L, Langevin C, Descamps D, Rameix-Welti MA, Eléouët JF, Le Goffic R, Meunier N, , Respiratory syncytial virus tropism for olfactory sensory neurons in mice., J Neurochem 2020 Sep; 155(2): 137-153.
• 2020
  Laubreton D, Drajac C, Eléouët JF, Rameix-Welti MA, Lo-Man R, Riffault S, Descamps D, , Regulatory B Lymphocytes Colonize the Respiratory Tract of Neonatal Mice and Modulate Immune Responses of Alveolar Macrophages to RSV Infection in IL-10-Dependant Manner., Viruses 2020 Jul; 12(8): .
• 2020
  Sesterhenn F, Yang C, Bonet J, Cramer JT, Wen X, Wang Y, Chiang CI, Abriata LA, Kucharska I, Castoro G, Vollers SS, Galloux M, Dheilly E, Rosset S, Corthésy P, Georgeon S, Villard M, Richard CA, Descamps D, Delgado T, Oricchio E, Rameix-Welti MA, Más V, Ervin S, Eléouët JF, Riffault S, Bates JT, Julien JP, Li Y, Jardetzky T, Krey T, Correia BE, , De novo protein design enables the precise induction of RSV-neutralizing antibodies., Science 2020 May; 368(6492): .
• 2020
  Blockus S, Sake SM, Wetzke M, Grethe C, Graalmann T, Pils M, Le Goffic R, Galloux M, Prochnow H, Rox K, Hüttel S, Rupcic Z, Wiegmann B, Dijkman R, Rameix-Welti MA, Eléouët JF, Duprex WP, Thiel V, Hansen G, Brönstrup M, Haid S, Pietschmann T, , Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry., Antiviral Res 2020 May; 177(): 104774.
• 2020
  Pålsson SA, Dondalska A, Bergenstråhle J, Rolfes C, Björk A, Sedano L, Power UF, Rameix-Welti MA, Lundeberg J, Wahren-Herlenius M, Mastrangelo P, Eleouet JF, Le Goffic R, Galloux M, Spetz AL, , Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection., Front Immunol 2020 ; 11(): 580547.
• 2020
  Hara K, Yaita K, Khamrin P, Kumthip K, Kashiwagi T, Eléouët JF, Rameix-Welti MA, Watanabe H, , A small fragmented P protein of respiratory syncytial virus inhibits virus infection by targeting P protein., J Gen Virol 2020 Jan; 101(1): 21-32.
• 2019
  Bouillier C, Cosentino G, Léger T, Rincheval V, Richard CA, Desquesnes A, Sitterlin D, Blouquit-Laye S, Eléouët JF, Gault E, Rameix-Welti MA, , The Interactome analysis of the Respiratory Syncytial Virus protein M2-1 suggests a new role in viral mRNA metabolism post-transcription., Sci Rep 2019 Oct; 9(1): 15258.
• 2019
  Fu YH, Xu ZX, Jiang N, Zheng YP, Rameix-Welti MA, Jiao YY, Peng XL, Wang Y, Eleouet JF, Cen S, He JS, , High-throughput screening of active compounds against human respiratory syncytial virus., Virology 2019 Sep; 535(): 171-178.
• 2019
  Ashraf U, Tengo L, Le Corre L, Fournier G, Busca P, McCarthy AA, Rameix-Welti MA, Gravier-Pelletier C, Ruigrok RWH, Jacob Y, Vidalain PO, Pietrancosta N, Crépin T, Naffakh N, , Destabilization of the human RED-SMU1 splicing complex as a basis for host-directed antiinfluenza strategy., Proc Natl Acad Sci U S A 2019 May; 116(22): 10968-10977.
• 2019
  Bouillier C, Rincheval V, Sitterlin D, Blouquit-Laye S, Desquesnes A, Eléouët JF, Gault E, Rameix-Welti MA, , Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses., J Vis Exp 2019 Apr; (146): .
• 2019
  Sesterhenn F, Galloux M, Vollers SS, Csepregi L, Yang C, Descamps D, Bonet J, Friedensohn S, Gainza P, Corthésy P, Chen M, Rosset S, Rameix-Welti MA, Éléouët JF, Reddy ST, Graham BS, Riffault S, Correia BE, , Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen., PLoS Biol 2019 Feb; 17(2): e3000164.
• 2019
  Maxime Fusade-Boyer, Gabriel Dupré, P. Bessière, Samira Khiar, Charlotte Quentin-Froignant, Cécile Beck, Sylvie Lecollinet, Marie-Anne Rameix-Welti, Jean-François Eléouët, Frédéric Tangy, Barbora Lajoie Halova, Stéphane Bertagnoli, Pierre-Olivier Vidalain, Franck Gallardo, Romain Volmer, Evaluation of the Antiviral Activity of Sephin1 Treatment and Its Consequences on eIF2α Phosphorylation in Response to Viral Infections, Frontiers in Immunology, 2019, 10, pp.134. ⟨10.3389/fimmu.2019.00134⟩.
• 2018
  Richard CA, Rincheval V, Lassoued S, Fix J, Cardone C, Esneau C, Nekhai S, Galloux M, Rameix-Welti MA, Sizun C, Eléouët JF, , RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcription., PLoS Pathog 2018 Mar; 14(3): e1006920.
• 2018
  Vasou A, Paulus C, Narloch J, Gage ZO, Rameix-Welti MA, Eléouët JF, Nevels M, Randall RE, Adamson CS, , Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice., Antiviral Res 2018 Feb; 150(): 79-92.
• 2018
  Cagno V, Andreozzi P, D'Alicarnasso M, Jacob Silva P, Mueller M, Galloux M, Le Goffic R, Jones ST, Vallino M, Hodek J, Weber J, Sen S, Janeček ER, Bekdemir A, Sanavio B, Martinelli C, Donalisio M, Rameix Welti MA, Eleouet JF, Han Y, Kaiser L, Vukovic L, Tapparel C, Král P, Krol S, Lembo D, Stellacci F, , Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism., Nat Mater 2018 Feb; 17(2): 195-203.
• 2017
  Rincheval V, Lelek M, Gault E, Bouillier C, Sitterlin D, Blouquit-Laye S, Galloux M, Zimmer C, Eleouet JF, Rameix-Welti MA, , Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus., Nat Commun 2017 Sep; 8(1): 563.
• 2017
  Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O, , A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading., Antimicrob Agents Chemother 2017 Apr; 61(4): .
• 2017
  Zhivaki D, Lemoine S, Lim A, Morva A, Vidalain PO, Schandene L, Casartelli N, Rameix-Welti MA, Hervé PL, Dériaud E, Beitz B, Ripaux-Lefevre M, Miatello J, Lemercier B, Lorin V, Descamps D, Fix J, Eléouët JF, Riffault S, Schwartz O, Porcheray F, Mascart F, Mouquet H, Zhang X, Tissières P, Lo-Man R, , Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity., Immunity 2017 Feb; 46(2): 301-314.
• 2017
  Hervé PL, Deloizy C, Descamps D, Rameix-Welti MA, Fix J, McLellan JS, Eléouët JF, Riffault S, , RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine., Nanomedicine 2017 Feb; 13(2): 411-420.
• 2015
  Sourimant J, Rameix-Welti MA, Gaillard AL, Chevret D, Galloux M, Gault E, Eléouët JF, , Fine mapping and characterization of the L-polymerase-binding domain of the respiratory syncytial virus phosphoprotein., J Virol 2015 Apr; 89(8): 4421-33.
• 2015
  Munday DC, Wu W, Smith N, Fix J, Noton SL, Galloux M, Touzelet O, Armstrong SD, Dawson JM, Aljabr W, Easton AJ, Rameix-Welti MA, de Oliveira AP, Simabuco FM, Ventura AM, Hughes DJ, Barr JN, Fearns R, Digard P, Eléouët JF, Hiscox JA, , Interactome analysis of the human respiratory syncytial virus RNA polymerase complex identifies protein chaperones as important cofactors that promote L-protein stability and RNA synthesis., J Virol 2015 Jan; 89(2): 917-30.
• 2015
  Galloux M, Gabiane G, Sourimant J, Richard CA, England P, Moudjou M, Aumont-Nicaise M, Fix J, Rameix-Welti MA, Eléouët JF, , Identification and characterization of the binding site of the respiratory syncytial virus phosphoprotein to RNA-free nucleoprotein., J Virol 2015 Apr; 89(7): 3484-96.
• 2014
  Rameix-Welti MA, Le Goffic R, Hervé PL, Sourimant J, Rémot A, Riffault S, Yu Q, Galloux M, Gault E, Eléouët JF, , Visualizing the replication of respiratory syncytial virus in cells and in living mice., Nat Commun 2014 Oct; 5(): 5104.
• 2012
  Rudrawar S, Kerry PS, Rameix-Welti MA, Maggioni A, Dyason JC, Rose FJ, van der Werf S, Thomson RJ, Naffakh N, Russell RJ, von Itzstein M, , Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility., Org Biomol Chem 2012 Nov; 10(43): 8628-39.
• 2011
  Chase GP, Rameix-Welti MA, Zvirbliene A, Zvirblis G, Götz V, Wolff T, Naffakh N, Schwemmle M, , Influenza virus ribonucleoprotein complexes gain preferential access to cellular export machinery through chromatin targeting., PLoS Pathog 2011 Sep; 7(9): e1002187.
• 2011
  Ge X, Rameix-Welti MA, Gault E, Chase G, dos Santos Afonso E, Picard D, Schwemmle M, Naffakh N, , Influenza virus infection induces the nuclear relocalization of the Hsp90 co-chaperone p23 and inhibits the glucocorticoid receptor response., PLoS One 2011 ; 6(8): e23368.
• 2011
  Papillard-Marechal S, Enouf V, Schnuriger A, Vabret A, Macheras E, Rameix-Welti MA, Page B, Freymuth F, van der Werf S, Garbarg-Chenon A, Chevallier B, Gaillard JL, Gault E, , Monitoring epidemic viral respiratory infections using one-step real-time triplex RT-PCR targeting influenza A and B viruses and respiratory syncytial virus., J Med Virol 2011 Apr; 83(4): 695-701.
• 2011
  Rameix-Welti MA, Munier S, Le Gal S, Cuvelier F, Agou F, Enouf V, Naffakh N, van der Werf S, , Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution., Antivir Ther 2011 ; 16(4): 597-603.
• 2010
  Rudrawar S, Dyason JC, Rameix-Welti MA, Rose FJ, Kerry PS, Russell RJ, van der Werf S, Thomson RJ, Naffakh N, von Itzstein M, , Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase., Nat Commun 2010 Nov; 1(): 113.
• 2010
  Bienaime F, Dragon-Durey MA, Regnier CH, Nilsson SC, Kwan WH, Blouin J, Jablonski M, Renault N, Rameix-Welti MA, Loirat C, Sautés-Fridman C, Villoutreix BO, Blom AM, Fremeaux-Bacchi V, , Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome., Kidney Int 2010 Feb; 77(4): 339-49.
• 2009
  Su B, Wurtzer S, Rameix-Welti MA, Dwyer D, van der Werf S, Naffakh N, Clavel F, Labrosse B, , Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA)., PLoS One 2009 Dec; 4(12): e8495.
• 2009
  Rameix-Welti MA, Zarantonelli ML, Giorgini D, Ruckly C, Marasescu M, van der Werf S, Alonso JM, Naffakh N, Taha MK, , Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules., Infect Immun 2009 Sep; 77(9): 3588-95.
• 2009
  Matsuoka Y, Swayne DE, Thomas C, Rameix-Welti MA, Naffakh N, Warnes C, Altholtz M, Donis R, Subbarao K, , Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice., J Virol 2009 May; 83(9): 4704-8.
• 2008
  Rameix-Welti MA, Tomoiu A, Dos Santos Afonso E, van der Werf S, Naffakh N, , Avian Influenza A virus polymerase association with nucleoprotein, but not polymerase assembly, is impaired in human cells during the course of infection., J Virol 2009 Feb; 83(3): 1320-31.
• 2008
  Rameix-Welti MA, Enouf V, Cuvelier F, Jeannin P, van der Werf S, , Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir., PLoS Pathog 2008 Jul; 4(7): e1000103.
• 2008
  Naffakh N, Tomoiu A, Rameix-Welti MA, van der Werf S, , Host restriction of avian influenza viruses at the level of the ribonucleoproteins., Annu Rev Microbiol 2008 ; 62(): 403-24.
• 2007
  Rameix-Welti MA, Régnier CH, Bienaimé F, Blouin J, Schifferli J, Fridman WH, Sautès-Fridman C, Frémeaux-Bacchi V, , Hereditary complement C7 deficiency in nine families: subtotal C7 deficiency revisited., Eur J Immunol 2007 May; 37(5): 1377-85.
• 2007
  Labadie K, Dos Santos Afonso E, Rameix-Welti MA, van der Werf S, Naffakh N, , Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells., Virology 2007 Jun; 362(2): 271-82.
• 2007
  Medeiros R, Rameix-Welti MA, Lorin V, Ribaud P, Manuguerra JC, Socie G, Scieux C, Naffakh N, van der Werf S, , Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus., Antivir Ther 2007 ; 12(4): 571-6.
• 2006
  Rameix-Welti MA, Agou F, Buchy P, Mardy S, Aubin JT, Véron M, van der Werf S, Naffakh N, , Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir., Antimicrob Agents Chemother 2006 Nov; 50(11): 3809-15.
• 2005
  Rameix-Welti MA, Chedani H, Blouin J, Alonso JM, Fridman WH, Fremeaux-Bacchi V, , [Neisseria meningitidis infection. Clinical criteria orienting towards a deficiency in the proteins of the complement]., Presse Med 2005 Mar; 34(6): 425-30.